These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

54 related articles for article (PubMed ID: 1388089)

  • 1. [Early intensification of treatment in diabetes using a combination of insulin and nicotinamide--effect on C-peptide levels and the course of the disease].
    Michalková D; Kolár J; Jancová E; Barák L; Sílesová J
    Bratisl Lek Listy; 1992 Jan; 93(1):11-5. PubMed ID: 1388089
    [TBL] [Abstract][Full Text] [Related]  

  • 2. A two year observational study of nicotinamide and intensive insulin therapy in patients with recent onset type 1 diabetes mellitus.
    Crinó A; Schiaffini R; Ciampalini P; Suraci MC; Manfrini S; Visalli N; Matteoli MC; Patera P; Buzzetti R; Guglielmi C; Spera S; Costanza F; Fioriti E; Pitocco D; Pozzilli P;
    J Pediatr Endocrinol Metab; 2005 Aug; 18(8):749-54. PubMed ID: 16200840
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Effects of nicotinamide and intravenous insulin therapy in newly diagnosed type 1 diabetes.
    Vidal J; Fernández-Balsells M; Sesmilo G; Aguilera E; Casamitjana R; Gomis R; Conget I
    Diabetes Care; 2000 Mar; 23(3):360-4. PubMed ID: 10868866
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Effect of two periods with intensified insulin treatment on B-cell function during the first 18 months of type 1 (insulin-dependent) diabetes mellitus.
    Krarup T; Madsbad S
    Diabete Metab; 1986 Oct; 12(5):256-60. PubMed ID: 3542618
    [TBL] [Abstract][Full Text] [Related]  

  • 5. A randomized trial of nicotinamide and vitamin E in children with recent onset type 1 diabetes (IMDIAB IX).
    Crinò A; Schiaffini R; Manfrini S; Mesturino C; Visalli N; Beretta Anguissola G; Suraci C; Pitocco D; Spera S; Corbi S; Matteoli MC; Patera IP; Manca Bitti ML; Bizzarri C; Pozzilli P;
    Eur J Endocrinol; 2004 May; 150(5):719-24. PubMed ID: 15132730
    [TBL] [Abstract][Full Text] [Related]  

  • 6. A trial of nicotinamide in newly diagnosed patients with type 1 (insulin-dependent) diabetes mellitus.
    Chase HP; Butler-Simon N; Garg S; McDuffie M; Hoops SL; O'Brien D
    Diabetologia; 1990 Jul; 33(7):444-6. PubMed ID: 2144835
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Residual B cell activity and insulin requirements in insulin-dependent diabetic patients treated from the beginning with high doses of nicotinamide. A two-year follow-up.
    Taboga C; Tonutti L; Noacco C
    Recenti Prog Med; 1994 Nov; 85(11):513-6. PubMed ID: 7855383
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Combination of nicotinamide and steroid versus nicotinamide in recent-onset IDDM. The IMDIAB II Study.
    Pozzilli P; Visalli N; Boccuni ML; Baroni MG; Buzzetti R; Fioriti E; Signore A; Cavallo MG; Andreani D; Lucentini L
    Diabetes Care; 1994 Aug; 17(8):897-900. PubMed ID: 7956639
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Randomized trial comparing nicotinamide and nicotinamide plus cyclosporin in recent onset insulin-dependent diabetes (IMDIAB 1). The IMDIAB Study Group.
    Pozzilli P; Visalli N; Boccuni ML; Baroni MG; Buzzetti R; Fioriti E; Signore A; Cavallo MG; Andreani D; Lucentini L
    Diabet Med; 1994; 11(1):98-104. PubMed ID: 8181261
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Effect of nicotinamide therapy upon B-cell function in newly diagnosed type 1 (insulin-dependent) diabetic patients.
    Mendola G; Casamitjana R; Gomis R
    Diabetologia; 1989 Mar; 32(3):160-2. PubMed ID: 2526767
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Plasma C-peptide levels and clinical remissions in recent-onset type I diabetic patients treated with cyclosporin A and insulin.
    Assan R; Feutren G; Sirmai J; Laborie C; Boitard C; Vexiau P; Du Rostu H; Rodier M; Figoni M; Vague P
    Diabetes; 1990 Jul; 39(7):768-74. PubMed ID: 2191883
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [Remission of diabetes during conventional insulin therapy or therapy controlled by use of an artificial pancreas].
    Mirouze J; Selam JL; Pham TC; Mendoza E
    Sem Hop; 1979 Feb 18-25; 55(7-8):354-9. PubMed ID: 220725
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Meta-analysis of nicotinamide treatment in patients with recent-onset IDDM. The Nicotinamide Trialists.
    Pozzilli P; Browne PD; Kolb H
    Diabetes Care; 1996 Dec; 19(12):1357-63. PubMed ID: 8941464
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Effect of nicotinamide on newly diagnosed type 1 diabetic children.
    Kamal M; Abbasy AJ; Muslemani AA; Bener A
    Acta Pharmacol Sin; 2006 Jun; 27(6):724-7. PubMed ID: 16723091
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Clinical investigations into the modification of the effect of endogenous and exogenous insulin by human proinsulin in type II and type I diabetics.
    Bellenberg S; Schröder KE; Schlüter KJ; Bottermann P; Zilker T; Gray P
    Horm Metab Res Suppl; 1988; 18():77-83. PubMed ID: 3056817
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [beta-Cell residual function in juvenile diabetes mellitus (author's transl)].
    Schober E; Schernthaner G; Frisch H
    Monatsschr Kinderheilkd; 1980 Dec; 128(12):776-9. PubMed ID: 6109242
    [TBL] [Abstract][Full Text] [Related]  

  • 17. C-peptide determination in the choice of treatment in diabetes mellitus.
    Koskinen P; Viikari J; Irjala K; Kaihola HL; Seppälä P
    Scand J Clin Lab Invest; 1985 Nov; 45(7):589-97. PubMed ID: 3906851
    [TBL] [Abstract][Full Text] [Related]  

  • 18. The effects of calcitriol and nicotinamide on residual pancreatic beta-cell function in patients with recent-onset Type 1 diabetes (IMDIAB XI).
    Pitocco D; Crinò A; Di Stasio E; Manfrini S; Guglielmi C; Spera S; Anguissola GB; Visalli N; Suraci C; Matteoli MC; Patera IP; Cavallo MG; Bizzarri C; Pozzilli P;
    Diabet Med; 2006 Aug; 23(8):920-3. PubMed ID: 16911633
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Double-blind randomized trial of nicotinamide on early-onset diabetes.
    Lewis CM; Canafax DM; Sprafka JM; Barbosa JJ
    Diabetes Care; 1992 Jan; 15(1):121-3. PubMed ID: 1531328
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [On C-peptide and some other parameters in children with insulin dependent diabetes mellitus (author's transl)].
    Koepp P; Kühnau J
    Monatsschr Kinderheilkd; 1982 Apr; 130(4):215-7. PubMed ID: 7048078
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 3.